Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
royalty payments
Biotech
BridgeBio taps investors for $1.25B to fund showdown with Pfizer
Facing a deep-pocketed rival, the biotech has struck deals to support an anticipated launch and a schedule of phase 3 readouts for other assets.
Nick Paul Taylor
Jan 18, 2024 8:04am
ImmunityBio inks $210M royalty deal to get cancer drug to market
Jan 2, 2024 7:41am
Royalty swoops in with $100M upfront for slice of Karuna's KarXT
Mar 23, 2023 9:45am